PTC Therapeutics Introduces Free At-Home Genetics Test for Cerebral Palsy
PTC Therapeutics Inc introduces PTC Pinpoint Direct-CP Spectrum, a no-charge, patient-initiated testing program in the United States for individuals who have symptoms consistent with, or a diagnosis of, cerebral palsy (CP) with no evidence of brain injury.